Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 10, 2008, Pages 3950-3957

  Capezzone, Marco ^a   Cantara, Silvia ^a   Marchisotta, Stefania ^a   Filetti, Sebastiano ^b   De Santi, Maria Margherita ^a   Rossi, Benedetta ^a   Ronga, Giuseppe ^b   Durante, Cosimo ^b   Pacini, Furio ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CHILD; CONTROLLED STUDY; FAMILIAL PAPILLARY THYROID CANCER; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIBLING; TELOMERE; THYROID CANCER;

EID: 53749108053     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0372     Document Type: Article

References (41)

1. Stoffer SS, Van Dyke DL, Bach JV 1986 Familial papillary carcinoma of the thyroid. Am J Med Genet 25:775-782
2. Loh KC 1997 Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 7:107-113
3. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH 1994 Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Nat Cancer Inst 86:1600-1608
4. Hemminki K, Eng C, Chen B 2005 Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab 90:5747-5753
5. Giardiello FM, Offerhaus GJA, Lee DH, Krush AJ, Tersmette AC, Booker SV, Kelley NC, Hamilton SR 1993 Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 34:1394-1396
6. Liaw D, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R 1997 Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64-67
7. Goto M, Miller RW, Ishikawa Y, Sugano H 1996 Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev 5:239-246
8. Stratakis CA, Courcoutsakies NA, Abati A, Filie A, Doppman JL, Carney A, Shawker T 1997 Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab 82:2037-2043
9. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J, Levillain P, Romeo G, Bonneau D 1998 A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Human Genet 63:1743-1748
10. Malchoff CD, Sarfarazi M, Tendler B, Forouhar F, Whalen G, Joshi V, Arnold A, Malchoff DM 2000 Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 85:1758-1764
11. McKay JD, Lesueur F, Jonard L, Pastore A, Williamson J, Hoffman L, Burgess J, Duffield A, Papotti M, Stark M, Sobol H, Maes B, Murat A, Kaariainen H, Bertholon-Gregoire M, Zini M, Rossing MA, Toubert ME, Bonichon F, Cavarec M, Bernard AM, Boneu A, Leprat F, Haas O, Lasset C, Schlumberger M, Canzian F, Goldgar DE, Romeo G 2001 Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 69:440-446
12. Ju Z, Rudolph L 2008 Telomere dysfunction and stem cell ageing. Biochimie (Paris) 90:24-32
13. Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I 2004 Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 36:447-449
14. Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Ki Hong W, Spitz MR 2003 Telomere dysfunction: a potential cancer predisposition factor. J Nat Cancer Inst 95:1211-1218
15. Gilson E, Londono-Vallejo A 2007 Telomere length profile in humans. Cell Cycle 6:1-9
16. Graakjaer J, Der-Sarkissian, Schmitz A, Bayer J, Thomas G, Kolvraa S, Londono-Vallejo A 2006 Allele-specific relative telomere lengths are inherited. Human Genet 119:344-350
17. Graakjaer J, Londono-Vallejo JA, Christensen K, Kolvraa S 2006 The pattern of chromosome-specific variations in telomere length in humans shows signs of heritability and is maintained through life. Ann NY Acad Sci 1067:311-316
18. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803
19. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM; The American Thyroid Association Guidelines Taskforce 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142
20. Cawthon RM 2002 Telomere measurement by quantitative PCR. Nucleic Acids Res 30:e47
21. Lantuejoul S, Soria JC, Morat L, Lorimier P, Moro-Sibilot D, Sabatier L, Brambilla C, Brambilla E 2005 Telomere shortening and telomere reverse transcriptase expression in preinvasive bronchial lesions. Clin Cancer Res 11:2074-2082
22. Malchoff CD, Malchoff DM 2002 The genetics of hereditary nonmedullary thyroid carcinoma. J Clin Endocrinol Metab 87:2455-2459
23. Gisselsson D, Jonson T, Petersen A, Strombeck B, Dal Cin P, Hoglund M, Mitelman F, Mertens F, Mandahl N 2001 Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci USA 98:12683-12688
24. Artandi SE, Alson S, Tietze MK, Sharpless NE, Ye S, Greenberg RA, Castrillon DH, Horner WJ, Weiler SR, Carrasco RD, DePinho RA 2002 Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci USA 99:8191-8196
25. Shibuya K, Fujisawa T, Hoshino H, Baba M, Saitoh Y, Iizasa T, Sekine Y, Suzuki M, Hiroshima K, Ohwada H 2001 Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung. Cancer 92:849-855
26. Kammori M, Takubo K, Nakamura K, Furugouri E, Endo H, Kanauchi H, Mimura Y, Kaminishi M 2000 Telomerase activity and telomere length in benign and malignant human thyroid tissues. Cancer Lett 159:175-181
27. Hiraga S, Ohnishi T, Izumoto S, Miyahara E, Kaneura Y, Matsumura H, Arita N 1998 Telomerase activity and alterations in telomere length in human brain tumors. Cancer Res 58:2117-2125
28. Brousset P, Chaouche N, Leprat F, Branet-Brousset F, Trouette H, Zenou RC, Merlio JP, Delsol G 1997 Telomerase activity in human thyroid carcinomas originating from the follicular cells. J Clin Endocrinol Metab 82:4214-4216
29. Umbricht CB, Saji M, Westra WH, Udelsman R, Zeiger MA, Sukumar S 1997 Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Res 57:2144-2147
30. Yashima K, Vuitch F, Gazdar AF, Fahey TJ 1997 Telomerase activity in benign and malignant thyroid diseases Surgery 122:1141-1145
31. Shen J, Terry MB, Gurvich I, Liano Y, Senie RT, Santella RM 2007 Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 67:5538-5544
32. Broberg K, Bjork J, Paulsson K, Hoglund M, Albin M 2005 Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer Carcinogenesis 26:1263-1271
33. Meeker AK, Hicks JL, Iacobuzio-Donahue CA, Montgomery EA, Westra WH, Chan TY, Ronnett BM, De Marzo AM 2004 Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 10:3317-3326
34. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S 1994 Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91:2900-2904
35. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW 1997 Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34
36. Nawrot TS, Staessen JA, Gardner JP, Aviv A 2004 Telomere length and possible link to X chromosome Lancet 363:507-510
37. Nordfjall K, Larefalk A, Lindgren P, Holmberg D, Roos G 2005 Telomere length and heredity: Indications of paternal inheritance. Proc Natl Acad Sci USA 102:16374-16378
38. Matthews P, Jones CJ, Skinner J, Haughton M, DeMicco C, Wynford-Thomas D 2001 Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications. J Pathol 194:183-193
39. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA 1997 hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-795
40. Londono-Vallejo A 2007 Telomere instability and cancer. Biochimie (Paris) 90:73-82
41. Zhang A, Zheng C, Lindvall C, Hou M, Ekedahl J, Lewensohn R, Yan Z, Yang X, Henriksson M, Blennow E, Nordenskjöld M, Zetterberg A, Björkholm M, Gruber A, Xu D 2000 Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res 15:6230-6235